HDAC4 and renal fibrosis: Initial biochemical analyses showed that both tasquinimod treatment and HDAC4 knockdown significantly increased renal GSH levels and reduced MDA levels compared with fibrotic controls (Fig. 6A–D), suggesting that HDAC4 contributes to ferroptosis during renal fibrosis progression.